Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Iatrogenic Aortocoronary Dissection During Coronary Intervention: A Case Series.
Catheter Cardiovasc Interv
November 2024
Cardiology Department, John Hunter Hospital, Newcastle, New South Wales, Australia.
Iatrogenic aortocoronary dissection (IAD) during percutaneous coronary intervention (PCI) is an uncommon and potentially life-threatening complication. Extension of dissection to the ascending aorta, despite early surgical management, carries a high morbidity and mortality risk. Depending on the severity of dissection, the approach to management ranges from monitoring to surgical intervention; more extensive dissections into the ascending aorta, typically more than 40 mm above the coronary ostium, are considered an indication for surgery.
View Article and Find Full Text PDFGraft Patency of No-Touch Saphenous Veins Used as Aortocoronary Bypass Grafts.
J Chest Surg
September 2023
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Background: This study evaluated the early, 1-year, and 3-year graft patency rates and mid-term clinical outcomes after no-touch saphenous veins (NT-SVs) were used as aortocoronary grafts in coronary artery bypass grafting (CABG).
Methods: In total, 101 patients who underwent CABG using NT-SVs as aortocoronary grafts were included. The 2 most common indications for performing aortocoronary grafting with NT-SVs were unavailability of the left internal thoracic artery (n=36) and moderate lesions where flow competition was expected (n=27).
Adverse Events With Intravascular Lithotripsy After Peripheral and Off-Label Coronary Use: A Report From the FDA MAUDE Database.
J Invasive Cardiol
December 2021
Minneapolis Heart Institute, 920 E. 28th Street #300, Minneapolis, MN 55407 USA.
Currently only the peripheral intravascular lithotripsy (IVL) device is approved for use in the United States. We queried the United States Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of failure related to the peripheral IVL device, when used for on- and off-label indications. There were 20 reports of use in peripheral artery disease interventions and 3 reports of off-label use in coronary interventions.
View Article and Find Full Text PDFFirst Experience with Fluorescence in Pediatric Laparoscopy.
European J Pediatr Surg Rep
January 2019
Department of Pediatric Surgery, Gregorio Marañon University Hospital, Madrid, Spain.
The use of intraoperative fluorescence images with indocyanine green (ICG) has recently been described as an aid in decision-making during surgical procedures in adults. We present our first experiences with different laparoscopic procedures performed in children using ICG fluorescence images. We have used ICG fluorescence imaging technique in varicocele ligation, two nephrectomies, cholecystectomy, and one case of aortocoronary fistula closure.
View Article and Find Full Text PDF[Update ESC-Guideline 2017: Dual Antiplatelet Therapy].
Dtsch Med Wochenschr
August 2018
Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf.
Unlabelled: DAPT DURATION DEPENDS ON THE INDIVIDUAL ISCHEMIC- VS.
Bleeding Risk: The updated ESC guidelines on dual antiplatelet therapy (DAPT) focus on individualization of therapy. It is recommended to plan DAPT duration depending on the individual ischemic- vs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!